| Rapid and effective vitamin D supplementation may present better clinical outcomes in COVID-19 (SARS-CoV-2) patients by altering serum INOS1, IL1B, IFNg, cathelicidin-LL37, and … MS Gönen, M Alaylıoğlu, E Durcan, Y Özdemir, S Şahin, D Konukoğlu, ... Nutrients 13 (11), 4047, 2021 | 73 | 2021 |
| Assessment of neuroendocrine changes and hypothalamo-pituitary autoimmunity in patients with COVID-19 MS Gonen, A De Bellis, E Durcan, G Bellastella, P Cirillo, L Scappaticcio, ... Hormone and Metabolic Research 54 (03), 153-161, 2022 | 18 | 2022 |
| The role of obesity in predicting the clinical outcomes of COVID-19 S Sahin, H Sezer, E Cicek, Y Yagız Ozogul, M Yildirim, TB Icli, ... Obesity Facts 14 (5), 481-489, 2021 | 16 | 2021 |
| Primary hypophysitis: experience of a single tertiary center OP Korkmaz, S Sahin, HM Ozkaya, T Apaydin, ES Durmaz, O Haliloglu, ... Experimental and Clinical Endocrinology & Diabetes 129 (01), 14-21, 2021 | 16 | 2021 |
| Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease E Durcan, S Turan, S Sahin, C Sulu, SS Taze, Y Kavla, HM Ozkaya, ... Pituitary 24, 589-599, 2021 | 10 | 2021 |
| Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleepquality, quality of life, and anxiety levels in people with type 2 diabetes mellitus? S Şahin, Ö Haliloğlu, ÖP Korkmaz, E Durcan, HR ŞAHİN, VD Yumuk, ... Turkish Journal of Medical Sciences 51 (2), 735-742, 2021 | 10 | 2021 |
| The effect of direct antiviral treatment on the depression, anxiety, fatigue and quality-of-life in chronic hepatitis C patients E Durcan, I Hatemi, A Sonsuz, B Canbakan, S Ozdemir, M Tuncer European Journal of Gastroenterology & Hepatology 32 (2), 246-250, 2020 | 10 | 2020 |
| Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia E Durcan, S Ozkan, HI Saygi, MT Dincer, OP Korkmaz, S Sahin, C Karaca, ... Journal of Diabetes 14 (4), 236-246, 2022 | 9 | 2022 |
| Machine learning as a clinical decision support tool for patients with acromegaly C Sulu, AB Bektaş, S Şahin, E Durcan, Z Kara, AN Demir, HM Özkaya, ... Pituitary 25 (3), 486-495, 2022 | 8 | 2022 |
| Transphobic attitudes of physicians who play an active role in the gender-affirming treatment in Turkey E Durcan, Y Kavla, S Sahin, OP Korkmaz, G Durcan, HM Ozkaya, ... Sexuality Research and Social Policy, 1-11, 2021 | 7 | 2021 |
| Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas HM Ozkaya, S Sahin, OP Korkmaz, E Durcan, HR Sahin, E Celik, ... Growth Hormone & IGF Research 55, 101356, 2020 | 7 | 2020 |
| Status of weight change, lifestyle behaviors, depression, anxiety, and diabetes mellitus in a cohort with obesity during the COVID-19 lockdown: Turk-com study group MM Fersahoğlu, T Fersahoğlu, NE Bulut, H Çiğiltepe, Ö Çeler, S Sancak, ... Obesity Facts 15 (4), 528-539, 2022 | 6 | 2022 |
| TransCOVID: does gender-affirming hormone therapy play a role in contracting COVID-19? E Durcan, S Turan, BE Bircan, S Yaylamaz, O Demirel, AN Demir, C Sulu, ... Journal of Sex & Marital Therapy 48 (4), 415-426, 2022 | 6 | 2022 |
| Effectiveness of cabergoline treatment in patients with acromegaly uncontrolled with SSAs: experience of a single tertiary center S Sahin, MC Fidan, OP Korkmaz, E Durcan, HM Ozkaya, P Kadioglu Experimental and Clinical Endocrinology & Diabetes 129 (09), 644-650, 2021 | 6 | 2021 |
| A genetic assessment of dopamine agonist-induced impulse control disorder in patients with prolactinoma S Sahin, T Sudutan, Y Kavla, E Durcan, YY Özogul, BC Poyraz, ... The Journal of Clinical Endocrinology & Metabolism 108 (6), e275-e282, 2023 | 5 | 2023 |
| Reliability of the corticotropin releasing hormone stimulation test for differentiating between ACTH dependent and independent Cushing syndrome OP Korkmaz, B Karayel, M Korkmaz, O Haliloglu, S Sahin, E Durcan, ... Acta Endocrinologica (Bucharest) 15 (2), 195, 2019 | 5 | 2019 |
| Acromegaly is associated with a distinct oral and gut microbiota S Sahin, A Gundogdu, U Nalbantoglu, P Kadioglu, Z Karaca, A Hacioglu, ... Pituitary 25 (3), 520-530, 2022 | 4 | 2022 |
| Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features S Sahin, G Yildiz, SH Oguz, O Civan, E Cicek, E Durcan, N Comunoglu, ... Pituitary 25 (3), 474-479, 2022 | 4 | 2022 |
| Endocrinological follow-up characteristics of people diagnosed with gender dysphoria in Turkey E Durcan, C Sulu, S Şahin, A Gioventikli, SE Dedeoğlu, I Azamet, ... Transgender Health 7 (3), 250-260, 2022 | 4 | 2022 |
| Fibroblast growth factor receptor-4 expression in pituitary adenomas is associated with aggressive tumor features E Durcan, FE Keskin, HM Ozkaya, S Sirolu, S Sahin, OP Korkmaz, ... Experimental and Clinical Endocrinology & Diabetes 130 (02), 125-133, 2022 | 4 | 2022 |
